These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8015351)

  • 1. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
    Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
    Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with antisense oligodeoxynucleotide to a conserved sequence of opioid receptors inhibits antinociceptive effects of delta subtype selective ligands.
    Lai J; Bilsky EJ; Porreca F
    J Recept Signal Transduct Res; 1995; 15(1-4):643-50. PubMed ID: 8903970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta 2-agonist antinociception.
    Lai J; Bilsky EJ; Rothman RB; Porreca F
    Neuroreport; 1994 May; 5(9):1049-52. PubMed ID: 8080957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
    Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse.
    Raffa RB; Martinez RP; Porreca F
    Eur J Pharmacol; 1992 Jun; 216(3):453-6. PubMed ID: 1330585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
    Mattia A; Vanderah T; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse.
    Tseng LF; Collins KA; Kampine JP
    Eur J Pharmacol; 1994 Jun; 258(1-2):R1-3. PubMed ID: 7925585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
    Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
    Qi JA; Mosberg HI; Porreca F
    Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.
    Bilsky EJ; Wang T; Lai J; Porreca F
    Neurosci Lett; 1996 Dec; 220(3):155-8. PubMed ID: 8994216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE; Hammond DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat.
    Ossipov MH; Kovelowski CJ; Nichols ML; Hruby VJ; Porreca F
    Pain; 1995 Sep; 62(3):287-293. PubMed ID: 8657428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
    Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
    J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.
    Wild KD; Horan PJ; Misicka A; Lipkowski A; Haaseth RC; Matsunaga TO; Hruby VJ; Toth G; Borsodi A; Yamamura HI
    Eur J Pharmacol; 1993 Jun; 246(1):25-31. PubMed ID: 8394818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
    Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
    J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse.
    Wang HQ; Kampine JP; Tseng LF
    Neuroscience; 1996 Nov; 75(2):445-52. PubMed ID: 8931008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with beta-endorphin facilitates the attenuation of delta-opioid receptor-mediated antinociception caused by delta-opioid receptor antisense oligodeoxynucleotide.
    Tseng LF; Narita M; Kampine JP
    Eur J Pharmacol; 1995 Dec; 287(2):169-72. PubMed ID: 8749031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.